- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05725226
Comparison Between 6Fr Vs 4Fr Double J Stent
Comparison Between Standard Vs Small Sized Double J Stent On Urological Symptoms Following RIRS And URSL: A Prospective Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The concept of the endoscopic access to the renal collecting systems for the diagnosis and treatment of upper urinary tract diseases was firstly introduced by V. Marshall who first described in 1964 the navigation in the renal pelvis with a rudimental flexible fiberscope. Retrograde intrarenal surgery (RIRS) by means of flexible ureterorenoscopes (fURSs) is considered one of the first-line treatment options for the active removal of renal stones. Ureteroscopic Lithotripsy (URSL) with the holmium laser is an effective and safe method for treating ureterolithiasis. After RIRS, one of the technical aspect is the placement of a double-J stent. The underlying rationale of ureteric stent is to allow the urinary flow to bypass internal or external obstructions, which impair its drainage. 'Double-J' refers to the most common type of stent design that was initially introduced by Finney in 1978. The term 'double-J' refers to the 'J' shape of each end of the stent, which is designed to anchor the stent and prevent its displacement. The mean size of normal ureter is 1.8mm with a standard deviation of 0.9 mm. The standard size for double J stents is typically 6 Fr. Few studies have been done comparing standard 6Fr and smaller sized DJ stent. One study published in March 2018 has shown 4Fr stent superior to 5Fr and 6Fr stent. A Randomised Control Trial (RCT) published in July 2018 has shown 4.8 Fr stent superior to 6Fr stent. To assess ureteral stent-related symptoms, Joshi et al. described and validated the Ureteral Stent Related Symptom Questionnaire (USSQ) in 2003. This self-administered questionnaire includes questions in six sections: urinary symptoms, body pain, general health, work performance, sexual matters, and additional problems. The total score is the sum of all questions. This questionnaire can define and compare stent-related symptoms.
DJ stent cause significant side effects. Dysuria, urinary frequency and urgency were reported by 40%, 50% and 55% of the patients, respectively. Flank pain, gross hematuria and fever was reported by 32%, 42% and 15% respectively. Anxiety and sleep disturbance were reported by 24% and 20% respectively, and 45% of patients reported impairment in their quality of life. Decreased libido was reported by 45%, and sexual dysfunction by 42% of men and 86% of women. With few studies showing small sized DJ stent causing less symptoms that standard 6Fr stents; our study aims to ascertain whether the previous studies were in line to change the standard size of DJ stent from 6Fr to smaller size, possibly 4Fr. 6Fr DJ stent is commonly used in our center. This study is aimed to compare standard size of DJ stent with small size in TUTH.
All cases of urinary tract stones requiring endourologic intervention will be sampled for study and cases meeting the inclusion criteria will be randomized via simple random sampling and computer generated numbers enclosed in a sealed envelope opened just prior to surgery, into two groups: Group A 6Fr and Group B 4Fr. All cases will receive a single dose of ceftriaxone intraoperatively. RIRS will be done using Ureteral Access Sheath (UAS) 9.5-11.5 Fr. DJ Stent 4Fr or 6Fr will be used and length of DJ Stent will be 26cm. Stent will be removed on the 14th postoperative day. Symptoms will be assessed on day 3, day 7 and on the day of stent removal. Stone Clearance will be assured after 1 month with ultrasonography of abdomen.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Bagmati
-
Kathmandu, Bagmati, Nepal, 977
- Tribhuvan University Teaching Hospital (TUTH), Institute of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age> 18yrs
- Informed Consent
- Sterile Urine culture prior to surgery
Exclusion Criteria:
- Bilateral DJ stenting
- Pregnancy
- Ureteral Strictures
- Complicated Surgery: Trauma, Bleeding
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Group 1 : 6Fr
Procedure: RIRs/URSL Confirmation of Renal/ Ureteric Stone with CT Urography Preanesthetic Check up and SterileUrine Culture obtained prior to surgery Perioperative Care: Inj.
Ceftriaxone 1gm IV stat dose , RIRS/ URSL performed using LASER Holmium lithotripsy 6Fr Double J stent is inserted to maintain the ureteric patency USSQ score obtained on Post operative Day 3, Day 7 and on the day of stone removal (Day 14) USG Abdomen and Pelvis is done on post operative Day 30 to confirm stone clearance.
|
Surgery will be performed by expert Urologist.
|
|
Experimental: Group 2: 4Fr
Procedure: RIRs/URSL Confirmation of Renal/ Ureteric Stone with CT Urography Preanesthetic Check up and SterileUrine Culture obtained prior to surgery Perioperative Care: Inj.
Ceftriaxone 1gm IV stat dose , RIRS/ URSL performed using LASER Holmium lithotripsy 4Fr Double J stent is inserted to maintain the ureteric patency USSQ score obtained on Post operative Day 3, Day 7 and on the day of stone removal (Day 14) USG Abdomen and Pelvis is done on post operative Day 30 to confirm stone clearance.
|
Surgery will be performed by expert Urologist.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To compare Ureteral Stent Symptom Questionnaire (USSQ) scores following 6Fr vs 4Fr Double J stenting
Time Frame: 14 days
|
Ureteral Stent Symptom Questionnaire score will be obtained by requesting the participants to fill the questionnaire.
The questionnaire will be filled on post operative Day 3, Day 7 and Day 14.
The maximum possible score is 169 and minimum score is 33.
Higher score indicates poor performance of Double J stent.
|
14 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To analyze the demographic pattern of patients undergoing URSL and RIRS in TUTH
Time Frame: 1day, on the date of admission
|
All demographic data are entered prior to surgery.
|
1day, on the date of admission
|
|
To compare the pain score, urinary symptoms, general health, sexual symptoms and work performance following 6Fr and 4Fr Double J Stenting
Time Frame: 14 days
|
Ureteral Stent Symptom Questionnaire score is the sum of the scores of pain symptoms, urinary symptoms, general health symptoms, work performance symptoms and sexual symptoms.
All these components will also be analyzed separately.
|
14 days
|
|
To compare stone clearance following 6Fr and 4Fr Double J stenting
Time Frame: Post operative day 30
|
Stone Clearance will be confirmed by ultrasonography done post operatively on Day 30.
|
Post operative day 30
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Pawan Rj Chalise, MCh Urology, Head of Department, Department of Urology and Kidney Transplant Surgery, TUTH
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Kidney Diseases
- Urologic Diseases
- Pathological Conditions, Anatomical
- Ureteral Diseases
- Urolithiasis
- Urinary Calculi
- Calculi
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Male Urogenital Diseases
- Kidney Calculi
- Nephrolithiasis
- Ureteral Calculi
- Ureterolithiasis
Other Study ID Numbers
- PKhatiwada
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Renal Stone
-
Ankara City Hospital BilkentCompletedRenal Stone | Ureter Stone | Kidney; Complications | Renal OxygenationTurkey
-
Wake Forest University Health SciencesCogenix Medical CorporationWithdrawnKidney Stone | Renal Stone | Ureter StoneUnited States
-
Ain Shams UniversityCompletedPercutaneous Nephrolithotomy (PCNL) | Renal Stone DiseaseEgypt
-
Kırıkkale UniversityCompletedKidney Calculi Nephrolithiasis Urolithiasis Renal Stone
-
University of Wisconsin, MadisonCompletedSurgery | Stone Ureter | Stone;RenalUnited States
-
Mansoura UniversityRecruitingUrinary Stones | Renal StoneEgypt
-
Société Internationale d'UrologieCompletedStone Ureter | Stone, Kidney | Stone;RenalUnited States, China, Korea, Republic of, Malaysia, Saudi Arabia, Greece, India, Indonesia, Iran, Islamic Republic of, Iraq, Kenya, Romania, South Africa, Taiwan, Turkey
-
Shiraz University of Medical SciencesCompletedRenal Pelvis Stone >3cmIran, Islamic Republic of
-
University of MichiganColoplast A/SCompletedRenal Stone | Ureteral StoneUnited States
-
National Cheng-Kung University HospitalCompleted
Clinical Trials on Double J Stent 6Fr x 26cms
-
Instituto Mexicano del Seguro SocialCompletedUrinary Complications | Kidney Transplant | Double J StentMexico
-
Bir HospitalNepal Health Research CouncilNot yet recruitingStent Related SymptomsNepal
-
Rabin Medical CenterCompleted
-
Tribhuvan University Teaching Hospital, Institute...CompletedBacterial Colonization in Double J Ureteral StentNepal
-
Turku University HospitalKuopio University Hospital; Satakunta Central Hospital; Jyväskylä Central HospitalRecruitingKidney Stone | Urinary Tract StoneFinland
-
Unity Health TorontoTerminated
-
Université de SousseCompleted
-
Ankara Training and Research HospitalNot yet recruitingKidney Stone | Ureter Obstruction | Stent ComplicationTurkey
-
Asan Medical CenterUnknownMalignant Ureteral ObstructionKorea, Republic of
-
Beni-Suef UniversityRecruitingUrolithiasis | Ureteral Calculi | Ureteral Stent-Related SymptomsEgypt